Effervescent Cold Relief Interactions
There are 764 drugs known to interact with Effervescent Cold Relief (aspirin / chlorpheniramine / phenylephrine), along with 17 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 86 are major, 653 are moderate, and 25 are minor.
- View all 764 medications that may interact with Effervescent Cold Relief
- View Effervescent Cold Relief alcohol/food interactions (1)
- View Effervescent Cold Relief disease interactions (17)
Most frequently checked interactions
View interaction reports for Effervescent Cold Relief (aspirin / chlorpheniramine / phenylephrine) and the medicines listed below.
- albuterol
- Anti-Diarrheal (loperamide)
- azelastine nasal
- Basaglar (insulin glargine)
- Bayer Aspirin (aspirin)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- diltiazem
- diphenhydramine
- doxazosin
- Eliquis (apixaban)
- escitalopram
- finasteride
- Jardiance (empagliflozin)
- Kaopectate (bismuth subsalicylate)
- nystatin topical
- pantoprazole
- silodosin
- trazodone
- valacyclovir
Effervescent Cold Relief alcohol/food interactions
There is 1 alcohol/food interaction with Effervescent Cold Relief (aspirin / chlorpheniramine / phenylephrine).
Effervescent Cold Relief disease interactions
There are 17 disease interactions with Effervescent Cold Relief (aspirin / chlorpheniramine / phenylephrine) which include:
- coagulation
- asthma
- GI toxicity
- renal dysfunction
- Reye's syndrome
- cardiovascular disease
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- anemia
- dialysis
- G-6-PD deficiency
- hepatotoxicity
- BPH
- diabetes
- glaucoma
Report options
More about Effervescent Cold Relief (aspirin / chlorpheniramine / phenylephrine)
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
